MONOLITHIC POWER SYSTEMS INC
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Business
Monolithic Power Systems, Inc. (the “Company”) was incorporated in the State of California on August 22, 1997. On November 17, 2004, the Company was reincorporated in the State of Delaware. MPS is a fabless global company that provides high-performance, semiconductor-based power electronics solutions. MPS’s mission is to reduce energy and material consumption to improve all aspects of quality of life and create a sustainable future.
Basis of Presentation
The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions used in these consolidated financial statements primarily include those related to income tax valuation allowances and stock-based compensation. Actual results could differ from these estimates and assumptions, and any such differences may be material to the Company’s consolidated financial statements.
Foreign Currency
The functional currency of the Company’s foreign subsidiaries is the local currency, with the exception of certain subsidiaries that invoice revenues in U.S. Dollars. Some subsidiaries are located in China, Taiwan and Europe, which utilize the Renminbi, the New Taiwan Dollar and the Euro as their currencies, respectively. Accordingly, assets and liabilities of the foreign subsidiaries are translated using exchange rates in effect at the end of the period. Revenue and costs are translated using average exchange rates for the period. The resulting translation adjustments are recorded in accumulated other comprehensive loss on the Consolidated Balance Sheets.
In addition, the Company incurs foreign currency exchange gains or losses related to certain transactions, including intercompany transactions, that are denominated in a currency other than the functional currency. Foreign currency exchange gains and losses in connection with the remeasurement and settlement of the balances were reported in other income, net, on the Consolidated Statements of Operations and were not material in any of the periods presented.
For intercompany transactions that are of a long-term investment nature, the Company records the foreign currency exchange gains and losses in accumulated other comprehensive loss on the Consolidated Balance Sheets.
Cash Equivalents and Debt Investments
The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents. The Company may classify investments with maturities beyond one year as short-term based on the nature of the investments and their availability for use in current operations.
Cash equivalents are stated at cost, which approximates fair market value. The Company’s short-term and long-term debt investments are classified as available-for-sale securities and are stated at their fair market value, with unrealized gains and losses recorded in accumulated other comprehensive loss on the Consolidated Balance Sheets. Premiums and discounts on debt investments are generally amortized or accreted over the life of the related available-for-sale securities. Interest income is recognized when earned. The cost of investments sold is determined on the basis of the specific identification method.
Available-for-sale investments are subject to impairment reviews when the fair value is below the amortized cost basis. If the Company determines that the decline in fair value below the amortized cost basis is due to credit-related factors, the impairment is recognized as an allowance on the Consolidated Balance Sheets with a corresponding adjustment to earnings. An impairment that is not credit-related is recognized in accumulated other comprehensive loss on the Consolidated Balance Sheets. If the Company intends to sell the impaired investments, or more likely than not will be required to sell such investments before recovering the amortized cost basis, the entire impairment amount is recognized in earnings with a corresponding adjustment to the amortized cost basis.
Fair Value of Financial Instruments
Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value, the Company considers the principal or most advantageous market in which the Company would transact, as well as assumptions that market participants would use when pricing the assets or liabilities. Fair value is estimated by applying the fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels, and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. See Note 5 for additional information on the fair value of the Company’s financial instruments.
Inventory Valuation
Inventories are valued at the lower of standard cost (which approximates actual cost determined on a first-in first-out basis) and estimated net realizable value. The Company writes down excess and obsolete inventories based on their age and forecasted demand, which includes estimates taking into consideration the Company’s revenue forecast, outlook on market and economic conditions, technology changes, new product introductions and changes in strategic direction. Actual demand may differ from forecasted demand, and such a difference may have a material effect on recorded inventory values. When the Company records a write-down on inventory, it establishes a new, lower cost basis for that inventory, and subsequent changes in facts and circumstances will not result in the restoration or increase in that newly established cost basis.
Property and Equipment
Property and equipment are stated at cost. Depreciation commences when an asset is placed in service and available for its intended use. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Buildings and building improvements have estimated useful lives of 20 to 40 years. Leasehold improvements are amortized over the shorter of the estimated useful lives or the lease period. Lab equipment and production equipment have estimated useful lives ofthree toten years. Software has estimated useful lives ofone toseven years. Transportation equipment has estimated useful lives of 5 to 20 years. Furniture and fixtures have estimated useful lives ofthree tofive years. Land is not depreciated.
Goodwill
Goodwill represents the excess of the fair value of purchase consideration over the fair value of net tangible and identified intangible assets as of the date of acquisition. Goodwill is not amortized. The Company tests goodwill for impairment at least annually in the fourth quarter of each year, or whenever events or changes in circumstances indicate that goodwill may be impaired. The Company has elected to first assess the qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it is more likely than not that the fair value of the reporting unit is less than the carrying amount, then a quantitative goodwill impairment test is performed to measure the impairment loss. No impairment of goodwill has been identified in any of the periods presented.
Impairment of Long-Lived Assets
The Company evaluates its long-lived assets other than goodwill for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. An impairment loss would be recognized when the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Such impairment loss would be measured as the difference between the carrying amount of the asset and its fair value based on the present value of estimated future cash flows. The Company did not record material impairments in any of the periods presented.
Deferred Compensation Plan
The Company has a non-qualified, unfunded deferred compensation plan, which provides certain key employees, including executive officers, with the ability to defer the receipt of compensation in order to accumulate funds for retirement on a tax deferred basis. The Company does not make contributions to the plan or guarantee returns on the investments. The Company is responsible for the plan’s administrative expenses. Participants’ deferrals and investment gains and losses remain as the Company’s liabilities and the underlying assets are subject to claims of general creditors.
The liabilities for compensation deferred under the plan are recorded at fair value as of the end of each reporting period. Changes in the fair value of the liabilities are included in cost of revenue and operating expenses on the Consolidated Statements of Operations. The Company manages the risk of changes in the fair value of the liabilities by electing to match the liabilities with investments in corporate-owned life insurance policies, mutual funds and money market funds that offset a substantial portion of the exposure. The investments are recorded at the cash surrender value of the corporate-owned life insurance policies, and at the fair value of the mutual funds and money market funds. Changes in the cash surrender value of the corporate-owned life insurance policies and the fair value of mutual fund and money market fund investments are included in other income, net, on the Consolidated Statements of Operations. The following table summarizes the deferred compensation plan balances on the Consolidated Balance Sheets (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan asset components: | ||
| Cash surrender value of corporate-owned life insurance policies | $31,612 | $27,249 |
| Fair value of mutual funds and money market funds | 75,484 | 65,337 |
| Total | $107,096 | $92,586 |
| Deferred compensation plan assets reported in: | ||
| Other long-term assets | $107,096 | $92,586 |
| Deferred compensation plan liabilities reported in: | ||
| Accrued compensation and related benefits | $3,707 | $2,323 |
| Other long-term liabilities | 103,954 | 93,653 |
| Total | $107,661 | $95,976 |
Revenue Recognition
The Company recognizes revenue when it transfers control of promised goods or services to its customers in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. See Note 3 for further discussion.
R&D
Costs incurred in R&D are expensed as incurred.
Product Warranty Reserve and Rework
The Company generally provides either aone- ortwo-year warranty against defects in materials and workmanship and will repair the products, provide replacements at no charge to customers or issue a refund. As they are considered assurance-type warranties, the Company does not account for them as separate performance obligations. The Company accrues for warranty and rework costs upon evaluation of customer specific claims. Historically, the Company’s warranty obligations and rework costs associated with product-related claims have not been material. The estimated amount of product warranty and rework liabilities was $10.1 million, $5.4 million, and $16.9 million for the periods ended December 31, 2025, 2024 and 2023.
Leases
The Company determines if an arrangement is a lease at inception. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease right-of-use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term, and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date based on the present value of remaining lease payments over the lease term. ROU assets also include any initial direct costs incurred and prepaid lease payments, less lease incentives received. Because the implicit rate in each lease is not readily determinable, the Company uses its estimated incremental borrowing rate to determine the present value of the remaining lease payment. The Company recognizes operating lease costs on a straight-line basis over the lease term.
The Company does not record short-term leases with a term of 12 months or less at the commencement date on the Consolidated Balance Sheets. For lease arrangements that contain lease and non-lease components, the Company accounts for them as single lease components.
Stock-Based Compensation
The Company’s restricted stock units (“RSUs”) include time-based RSUs, RSUs with performance conditions (“PSUs”), and RSUs with market conditions (“MSUs”). The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award. The fair value of time-based RSUs is determined based on the grant date stock price. The fair value of all other awards, including PSUs that have a purchase price adjustment and MSUs, is determined based on the Monte Carlo simulation model.
The valuation model considers inputs including stock price, expected volatility, expected term of awards, risk-free interest rate, and expected dividend yield. Expected volatility used in the model is determined based on historical volatility of the Company’s stock price for the period, which corresponds to the expected term of the awards, immediately preceding the granting of the awards.
Compensation expense related to awards with service conditions is recorded on a straight-line basis over the requisite service period. Compensation expense related to awards subject to performance or market conditions is recognized over the requisite service period for each separately vesting tranche. For awards with market conditions, compensation expense is not reversed if the market conditions are not satisfied. For awards with performance conditions, the Company recognizes compensation expense when it becomes probable that the performance goals will be achieved. Management performs the probability assessment on a quarterly basis by reviewing external factors, such as macroeconomic conditions and analog industry revenue forecasts, and internal factors, such as our business and operational objectives and revenue forecasts. Changes in the probability assessment of achievement of the performance conditions are accounted for in the period of change by recording a cumulative catch-up adjustment as if the new estimate had been applied since the service inception date. Any previously recognized compensation expense is reversed if the performance conditions are not expected to be satisfied as a result of management’s assessment.
The Company accounts for forfeitures of equity awards when they occur.
Accounting for Income Taxes
The Company recognizes federal, state and foreign current tax liabilities or assets based on its estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. The Company also recognizes federal, state and foreign deferred tax assets or liabilities for its estimate of future tax effects attributable to temporary differences and carryforwards. The Company records a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
The Company’s calculation of current and deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. The Company’s estimates of current and deferred tax assets and liabilities may change based on, in part, added certainty, finality or uncertainty to an anticipated outcome, changes in accounting or tax laws in the U.S. or foreign jurisdictions where the Company operates, or changes in other facts or circumstances. In addition, the Company recognizes liabilities for potential U.S. and foreign income tax for uncertain income tax positions taken on its tax returns if it has less than a 50% likelihood of being sustained. If the Company determines that payment of these amounts is unnecessary or if the recorded tax liability is less than its current assessment, the Company may be required to recognize an income tax benefit or additional income tax expense in its financial statements in the period such determination is made. The Company has calculated its uncertain tax positions which were attributable to certain estimates and judgments.
Litigation and Contingencies
The Company is a party to actions and proceedings in the ordinary course of business, including challenges to the enforceability or validity of its intellectual property, claims that the Company’s products infringe on the intellectual property rights of others, and employment matters. The Company is subject to litigation initiated by its stockholders. The pending proceedings involve complex questions of fact and law and will require the expenditure of significant funds and the diversion of other resources to prosecute and defend.
In addition, from time to time, the Company becomes aware that it is subject to other contingent liabilities. When this occurs, the Company will evaluate the appropriate accounting for the potential contingent liabilities to determine whether a contingent liability should be recorded. In making this determination, management may, depending on the nature of the matter, consult with internal and external legal counsel and technical experts. Based on the facts and circumstances in each matter, the Company uses its judgment to determine whether it is probable that a contingent loss has occurred and whether the amount of such loss can be estimated. If the Company determines a loss is probable and estimable, the Company records a contingent loss. In determining the amount of a contingent loss, the Company takes into account advice received from experts for each specific matter regarding the status of legal proceedings, settlement negotiations, prior case history and other factors.
Should the judgments and estimates made by management need to be adjusted as additional information becomes available, the Company may need to record additional contingent losses. Alternatively, if the judgments and estimates made by management are adjusted, for example, if a particular contingent loss does not occur, the contingent loss recorded would be reversed.
Net Income per Share
Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding for the period. Diluted net income per share reflects the potential dilution from contingently issuable shares and is calculated using the treasury stock method. Contingently issuable shares, including all types of equity awards, are considered outstanding shares of common stock and included in basic net income per share as of the date that all necessary conditions to earn the awards have been satisfied. Prior to the end of the contingency period, the number of contingently issuable shares included in diluted net income per share is based on the number of shares, if any, that would be issuable under the terms of the arrangement at the end of the reporting period as if the end of the reporting period were the end of the contingency period.
Comprehensive Income
Comprehensive income represents the change in the Company’s net assets during the period from non-owner sources. Accumulated other comprehensive loss presented on the Consolidated Balance Sheets primarily consists of foreign currency translation adjustments.
Recently Adopted Accounting Pronouncement
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which aims to improve an entity’s income tax disclosures around its effective rate reconciliation, income taxes paid, disaggregation of income before income taxes and income tax expense. The Company adopted the guidance during the year ended December 31, 2025 and applied the new disclosure requirements prospectively to its 2025 annual period. Prior period disclosures have not been adjusted to reflect the new disclosure requirements. Refer to Note 13 for further information.
New Accounting Pronouncement Not Yet Adopted as of December 31, 2025
In November 2024, the FASB issued ASU 2024-03,Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which aims to provide more detailed information about the types of expenses in commonly presented expense captions. The Company will adopt this standard in its Form 10-K for the fiscal year ending December 31, 2027. The Company is evaluating the impact of adoption on its Consolidated Financial Statements.
2. RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
In connection with the preparation of the Company’s Consolidated Financial Statements as of and for the fiscal year ended December 31, 2025, the Company discovered that in the prior year it had not appropriately accounted for deferred income taxes associated with a one-time tax incentive granted by a certain foreign jurisdiction. The restatement results in a decrease to income tax benefit, net and deferred income taxes by $194.6 million in the consolidated financial statements as of and for the year ended December 31, 2024.
The misstatement was material to the previously issued financial statements of the Company and as a result, the Company has restated its Consolidated Balance Sheet, Consolidated Statement of Operations, Consolidated Statement of Comprehensive Income, Consolidated Statement of Stockholders’ Equity, and Consolidated Statement of Cash Flows as of and for the year ended December 31, 2024 presented herein. The restatement includes adjustments to deferred tax assets, net, deferred tax liabilities, retained earnings, income tax benefit, net, net income, and net income per share.
The impacts of the restatement are summarized below (in thousands, except per-share amounts):
| RESTATED CONSOLIDATED BALANCE SHEET · As Previously Reported · Impact of Restatement · As Restated | ||||
|---|---|---|---|---|
| Deferred tax assets, net | $1,326,840 | (101,275) | $1,225,565 | |
| Total assets | $3,617,097 | (101,275) | $3,515,822 | |
| Deferred tax liabilities | $ | - | 93,367 | $93,367 |
| Total liabilities | $471,330 | 93,367 | $564,697 | |
| Retained earnings | $2,487,461 | (194,642) | $2,292,819 | |
| Total stockholders’ equity | $3,145,767 | (194,642) | $2,951,125 | |
| Total liabilities and stockholders’ equity | $3,617,097 | (101,275) | $3,515,822 | |
| RESTATED CONSOLIDATED STATEMENT OF OPERATIONS | As Previously Reported | Impact of Restatement | As Restated |
|---|---|---|---|
| Income tax benefit, net | $(1,213,788) | 194,642 | $(1,019,146) |
| Net income | $1,786,700 | (194,642) | $1,592,058 |
| Net income per share: | |||
| Basic | $36.76 | (4.00) | $32.76 |
| Diluted | $36.59 | (3.99) | $32.60 |
| Retained Earnings | |||
|---|---|---|---|
| RESTATED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY | As Previously Reported | Impact of Restatement | As Restated |
| Net income | $1,786,700 | (194,642) | $1,592,058 |
| Balance as of December 31, 2024 | $2,487,461 | (194,642) | $2,292,819 |
| RESTATED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | As Previously Reported | Impact of Restatement | As Restated |
|---|---|---|---|
| Net income | $1,786,700 | (194,642) | $1,592,058 |
| Comprehensive income | $1,765,251 | (194,642) | $1,570,609 |
| RESTATED CONSOLIDATED STATEMENT OF CASH FLOWS | As Previously Reported | Impact of Restatement | As Restated |
|---|---|---|---|
| Net income | $1,786,700 | (194,642) | $1,592,058 |
| Deferred taxes, net | $(1,302,911) | 194,642 | $(1,108,269) |
All referenced amounts for prior period in these financial statements and the notes herein reflect the balances and amounts on a restated basis.
Refer to Note 17, Restatement of Previously Issued Condensed Consolidated Financial Statements, for restated interim financials for the quarterly periods ended March 31, 2025, June 30, 2025, and September 30, 2025.
3. REVENUE RECOGNITION
Revenue from Product Sales
The Company generates revenue primarily from product sales, which include assembled and tested ICs, power modules as well as dies in wafer form. The remaining revenue, which primarily consists of royalty revenue from licensing arrangements and revenue from wafer testing services performed for third parties, was not significant in any of the periods presented.
The Company derives a majority of its revenue from sales to customers located outside North America, with geographic revenue based on the customers’ ship-to locations. The following is a summary of revenue by geographic region for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| Country or Region | 2025 | 2024 | 2023 |
| China | $1,544,272 | $1,178,341 | $934,768 |
| Taiwan | 550,110 | 577,956 | 307,499 |
| South Korea | 252,737 | 167,899 | 169,867 |
| Southeast Asia | 148,136 | 78,765 | 85,150 |
| Europe | 113,533 | 86,899 | 132,620 |
| U.S. | 96,744 | 55,235 | 97,294 |
| Japan | 84,443 | 61,695 | 93,340 |
| Other | 484 | 310 | 534 |
| Total | $2,790,459 | $2,207,100 | $1,821,072 |
The Company sells its products to end customers primarily through third-party distributors and value-added resellers. For the years ended December 31, 2025, 2024 and 2023*,* 85%,89% and 86%, respectively, of the Company’s total sales were made through distribution arrangements. These distribution arrangements contain enforceable rights and obligations specific to those distributors and not the end customers. Purchase orders, which are generally governed by sales agreements or the Company’s standard terms of sale, set the final terms for unit price, quantity, shipping and payment agreed upon between the Company and the customer. The Company considers purchase orders to be contracts with the customers. The unit price as stated on the purchase orders is considered the observable, stand-alone selling price for the arrangements.
The following table summarizes those customers with sales equal to 10% or more of the Company’s total revenue for the periods presented:
| Year Ended December 31, | |||
|---|---|---|---|
| Customer | 2025 | 2024 | 2023 |
| Distributor A | 26% | 31% | 26% |
| Distributor B | 18% | 20% | 19% |
| Distributor C | 10% | * | 10% |
- Represents less than 10%.
The Company’s agreements with these third-party distributors were made in the ordinary course of business and may be terminated with or without cause by these distributors with advance notice. Although the Company may experience a short-term disruption in the distribution of its products and a short-term decline in revenue if its agreement with any of the distributors were terminated, the Company believes that such termination would not have a material adverse effect on its financial statements because it would be able to engage alternative distributors, resellers and other distribution channels to deliver its products to end customers within a relatively short period following any termination of the agreement with a distributor.
The Company recognizes revenue when it satisfies a performance obligation by transferring control of the promised goods or services to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company excludes taxes assessed by government authorities, such as sales taxes, from revenue.
Product sales consist of a single performance obligation that the Company satisfies at a point in time. The Company recognizes product revenue from distributors and direct end customers when the following events have occurred: (a) the Company has transferred physical possession of the products, (b) the Company has a present right to payment, (c) the customer has legal title to the products, and (d) the customer bears significant risks and rewards of ownership of the products. In accordance with the shipping terms specified in the contracts, these criteria are generally met when the products are shipped from the Company’s facilities (such as the “Ex Works” shipping term) or delivered to the customers’ locations (such as the “Delivered Duty Paid” shipping term).
Under certain consignment agreements, the Company recognizes revenue when customers consume products from the consigned inventory locations, at which time control transfers to the customers and the Company issues invoices.
Variable Consideration
The Company accounts for price adjustments and stock rotation rights as variable consideration that reduces the transaction price and recognizes that reduction in the same period the associated revenue is recognized. Certain distributors have limited stock rotation rights that permit the return of a small percentage of the previous six months’ purchases in accordance with the contract terms. The Company estimates the stock rotation returns using the expected value method based on an analysis of historical returns, and the current level of inventory in the distribution channel. The Company records a liability for the stock rotation reserve, with a corresponding reduction to revenue. In addition, the Company recognizes an asset for product returns which represents the right to recover products from the customers related to stock rotations, with a corresponding reduction to cost of revenue.
Contract Balances
Accounts Receivable:
The Company records a receivable when it has an unconditional right to receive consideration after the performance obligations are satisfied. The Company’s accounts receivable are short-term, with standard payment terms generally ranging from 30 to 90 days. The Company does not require its customers to provide collateral to support accounts receivable. The Company assesses collectability by reviewing accounts receivable on a customer-by-customer basis. To manage credit risk, management performs ongoing credit evaluations of the customers’ financial condition, monitors payment performance, and assesses current economic conditions, as well as reasonable and supportable forecasts of future economic conditions, that may affect collectability of the outstanding receivables. For certain customers, the Company requires standby letters of credit or advance payments prior to shipments of goods. The Company did not recognize any write-offs of accounts receivable or record any allowance for credit losses for the periods presented.
The following table summarizes those customers with accounts receivable equal to 10% or more of the Company’s total accounts receivable:
| December 31, | ||
|---|---|---|
| Customer | 2025 | 2024 |
| Distributor A | 35% | 28% |
| Distributor B | 14% | 29% |
| Distributor C | 11% | * |
- Represents less than 10%.
Practical Expedients
The Company has elected the practical expedient to expense sales commissions as incurred because the amortization period would have been one year or less.
The Company’s standard payment terms generally require customers to pay 30 to 90 days after the Company satisfies the performance obligations. For this reason, the Company has elected not to determine whether contracts with customers contain significant financing components.
The Company’s unsatisfied performance obligations primarily include products held in consignment arrangements and customer purchase orders for products that the Company has not yet shipped. Because the Company expects to fulfill these performance obligations within one year, the Company has elected not to disclose the amount of these remaining performance obligations.
4. CASH, CASH EQUIVALENTS AND INVESTMENTS
The following is a summary of the Company’s cash, cash equivalents and debt investments (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash | $969,628 | $679,949 |
| Money market funds | 129,674 | 11,867 |
| Certificates of deposit | 157,243 | 164,418 |
| Corporate debt securities | - | 6,712 |
| Auction-rate securities backed by student-loan notes | 49 | 148 |
| Total | $1,256,594 | $863,094 |
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Reported as: | ||
| Cash and cash equivalents | $1,099,302 | $691,816 |
| Short-term investments | 157,243 | 171,130 |
| Investment within other long-term assets | 49 | 148 |
| Total | $1,256,594 | $863,094 |
The following table summarizes the contractual maturities of the short-term and long-term available-for-sale investments as of December 31, 2025 (in thousands):
| Amortized Cost | Fair Value | |
|---|---|---|
| Due in less than 1 year | $57,179 | $57,179 |
| Due in 1 - 5 years | 100,064 | 100,064 |
| Due in greater than 5 years | 50 | 49 |
| Total | $157,293 | $157,292 |
Gross realized gains and losses recognized on the sales of available-for-sale investments were not material for the periods presented.
5. FAIR VALUE MEASUREMENTS
Fair Value Hierarchy
The Company has estimated the fair value of its financial assets by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
| ● | Level 1—includes instruments with quoted prices in active markets for identical assets. |
|---|
| ● | Level 2—includes instruments for which the valuations are based upon quoted market prices in active markets involving similar assets or inputs other than quoted prices that are observable for the assets. The market inputs used to value these instruments generally consist of market yields, recently executed transactions, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency. Pricing sources may include industry standard data providers, security master files from large financial institutions, and other third-party sources used to determine a daily market value. |
|---|
| ● | Level 3—includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. |
|---|
Financial Assets Measured at Fair Value on a Recurring Basis
The following tables detail the fair value of the Company’s financial assets measured on a recurring basis (in thousands):
| Total · Level 1 · Level 2 · Level 3 | ||||||
|---|---|---|---|---|---|---|
| Money market funds | $129,674 | $129,674 | $ | - | $ | - |
| Certificates of deposit | 157,243 | - | 157,243 | - | ||
| Auction-rate securities backed by student-loan notes | 49 | - | - | 49 | ||
| Mutual funds and money market funds under deferred compensation plan | 75,484 | 75,484 | - | - | ||
| Total | $362,450 | $205,158 | $157,243 | $49 | ||
| Total · Level 1 · Level 2 · Level 3 | ||||||
|---|---|---|---|---|---|---|
| Money market funds | $11,867 | $11,867 | $ | - | $ | - |
| Certificates of deposit | 164,418 | - | 164,418 | - | ||
| Corporate debt securities | 6,712 | - | 6,712 | - | ||
| Auction-rate securities backed by student-loan notes | 148 | - | - | 148 | ||
| Mutual funds and money market funds under deferred compensation plan | 65,337 | 65,337 | - | - | ||
| Total | $248,482 | $77,204 | $171,130 | $148 | ||
6. BALANCE SHEET COMPONENTS
Inventories
Inventories consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Raw materials | $107,801 | $91,851 |
| Work in process | 220,410 | 169,982 |
| Finished goods | 236,438 | 157,778 |
| Total | $564,649 | $419,611 |
Other Current Assets
Other current assets consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Other receivables (1) | $60,000 | $60,000 |
| Prepaids and other | 46,982 | 49,978 |
| Total | $106,982 | $109,978 |
| (1) | Other receivables relate to an annually refundable deposit made to a supplier under a long-term wafer supply agreement. |
Property and Equipment, Net
Property and equipment, net, consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Land | $53,151 | $50,681 |
| Production equipment and software | 469,626 | 340,691 |
| Buildings and improvements | 240,691 | 224,490 |
| Transportation equipment | 62,088 | 72,044 |
| Leasehold improvements | 25,798 | 18,301 |
| Furniture and fixtures | 17,279 | 13,472 |
| Construction in progress | 63,767 | 27,477 |
| Property and equipment, gross | 932,400 | 747,156 |
| Less: accumulated depreciation and amortization | (304,711) | (252,211) |
| Total property and equipment, net | $627,689 | $494,945 |
Depreciation and amortization expense on property and equipment was $50.0 million, $35.1 million and $40.0 million for the years ended December 31, 2025, 2024 and 2023, respectively.
Other Long-Term Assets
Other long-term assets consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan assets | $107,096 | $92,586 |
| Prepaid wafer purchases (1) | - | 60,000 |
| Other | 57,995 | 41,791 |
| Total | $165,091 | $194,377 |
| (1) | Prepaid wafer purchases relate to an annually refundable deposit made to a supplier under a long-term wafer supply agreement. |
Other Accrued Liabilities
Other accrued liabilities consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Dividends and dividend equivalents | $81,510 | $60,622 |
| Stock rotation and sales returns | 17,150 | 20,799 |
| Other | 46,470 | 46,702 |
| Total | $145,130 | $128,123 |
Other Long-Term Liabilities
Other long-term liabilities consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Deferred compensation plan liabilities | $103,954 | $93,653 |
| Operating lease liabilities | 19,972 | 12,974 |
| Dividend equivalents | 3,909 | 4,943 |
| Total | $127,835 | $111,570 |
7. LEASES
The Company has operating leases primarily for administrative, sales and marketing offices, manufacturing operations and R&D facilities, and employee housing units. These leases have remaining lease terms from less thanone year to 19 years. Some of these leases include options to renew the lease term for up tofive years or on a month-to-month basis. The Company does not have finance lease arrangements.
The following table summarizes the balances of operating lease ROU assets and liabilities (in thousands):
| December 31, | |||
|---|---|---|---|
| Financial Statement Line Item | 2025 | 2024 | |
| Operating lease ROU assets | Other long-term assets | $24,886 | $16,915 |
| Operating lease liabilities | Other accrued liabilities | $4,131 | $2,819 |
| Other long-term liabilities | $19,972 | $12,974 | |
The following tables summarize certain information related to the leases for the periods presented (in thousands, except percentages and years):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Lease costs: | |||
| Operating lease costs | $5,213 | $3,903 | $3,113 |
| Other | 3,556 | 2,840 | 2,120 |
| Total lease costs | $8,769 | $6,743 | $5,233 |
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash paid for amounts included in the measurement of lease liabilities: | |||
| Operating cash flows for operating leases | $4,832 | $4,346 | $2,954 |
| ROU assets obtained | $11,519 | $11,940 | $7,081 |
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Weighted-average remaining lease term (in years) | 9.3 | 11.5 |
| Weighted-average discount rate | 5.6% | 5.5% |
As of December 31, 2025, the maturities of the lease liabilities were as follows (in thousands):
| 2026 | $5,309 |
| 2027 | 5,082 |
| 2028 | 3,732 |
| 2029 | 2,957 |
| 2030 | 1,908 |
| Thereafter | 13,440 |
| Total remaining lease payments | 32,428 |
| Less: imputed interest | (8,325) |
| Total lease liabilities | $24,103 |
As of December 31, 2025, the Company had no operating leases that had not yet commenced.
8. STOCK-BASED COMPENSATION
2014 Equity Incentive Plan
In April 2013, the Board of Directors adopted the Company’s 2014 Equity Incentive Plan (the “2014 Plan”), which the Company’s stockholders approved in June 2013. In October 2014, the Board of Directors approved certain amendments to the 2014 Plan. The amended 2014 Plan became effective on November 13, 2014 and provided for the issuance of up to 5.5 million shares. In April 2020, the Board of Directors further amended and restated the amended 2014 Plan (the “Amended and Restated 2014 Plan”), which the Company’s stockholders approved in June 2020. The Amended and Restated 2014 Plan became effective on June 11, 2020 and provides for the issuance of up to 10.5 million shares. The Amended and Restated 2014 Plan will cease being available for new awards on June 11, 2030. As of December 31, 2025,3.6 million shares remained available for future issuance under the Amended and Restated 2014 Plan.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense as follows for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cost of revenue | $7,204 | $6,305 | $4,545 |
| Research and development | 49,247 | 45,626 | 36,611 |
| Selling, general and administrative | 171,040 | 153,709 | 108,555 |
| Total stock-based compensation expense | $227,491 | $205,640 | $149,711 |
| Tax benefit related to stock-based compensation (1) | $2,674 | $3,040 | $2,519 |
| (1) | Amount reflects the tax benefit related to stock-based compensation recorded for equity awards that are expected to generate tax deductions when they vest in future periods. Equity awards granted to the Company’s executive officers are subject to the tax deduction limitations set by Section 162(m) of the Internal Revenue Code. |
RSUs
The Company’s RSUs include time-based RSUs, PSUs, and MSUs. Vesting of awards with performance conditions or market conditions is subject to the achievement of pre-determined performance or market goals and the approval of such achievement by the Compensation Committee of the Board of Directors (the “Compensation Committee”). All awards include service conditions which require continued employment with or service to the Company.
A summary of RSU activity is presented in the table below (in thousands, except per share amounts):
| Total Time-based RSUs, PSUs and MSUs | |||
|---|---|---|---|
| Number of Shares · Weighted-Average Grant Date Fair Value Per Share | |||
| Outstanding at January 1, 2023 | 2,659 | $176.50 | |
| Granted | 363 | (1) | $444.86 |
| Vested | (911) | $177.54 | |
| Forfeited | (25) | $209.23 | |
| Outstanding at December 31, 2023 | 2,086 | $222.04 | |
| Granted | 402 | (1) | $584.49 |
| Vested | (778) | $133.62 | |
| Forfeited | (6) | $432.32 | |
| Outstanding at December 31, 2024 | 1,704 | $347.01 | |
| Granted | 317 | (1) | $576.98 |
| Vested | (1,226) | (2) | $290.55 |
| Forfeited | (24) | $473.09 | |
| Outstanding at December 31, 2025 | 771 | $535.78 | |
| (1) | Amount reflects the number of awards that may ultimately be earned based on management’s probability assessment of the achievement of performance conditions at each reporting period. |
| (2) | Amount includes shares that had not been issued as of December 31, 2025. |
The fair value related to vested RSUs, as of their respective vesting dates, was $1,254.3 million, $513.0 million and $461.3 million for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, unamortized compensation expense related to all outstanding RSUs was $208.0 million with a weighted-average remaining recognition period of approximatelytwo years.
Time-Based RSUs
For the years ended December 31, 2025, 2024 and 2023, the Compensation Committee granted 40,000,33,000 and 51,000 RSUs, respectively, with service conditions to non-executive employees and non-employee directors. The RSUs generally vest over four years for employees andone year for directors, subject to continued service with the Company.
PSUs and MSUs
2025 PSUs:
In February 2025, the Compensation Committee granted 50,000 PSUs to the executive officers, which represent the target number of shares that can be earned based on the degree of achievement of two sets of independent performance goals (the “2025 Executive PSUs”). For the first goal, the executive officers can earn up to 300% of the target number of the 2025 Executive PSUs based on the achievement of the Company’s three-year (2025 through 2027) average revenue growth rate in excess of the analog industry’s three-year average revenue growth rate as published by the Semiconductor Industry Association (the “SIA”). For the second goal, the executive officers can earn up to 200% of the target number of the 2025 Executive PSUs based on the achievement of the Company’s three-year (2025 through 2027) total stockholder return percentile ranking relative to the constituent entities in the Philadelphia Semiconductor Sector Index (the “PHLX Index”). For both goals, a percentage of the 2025 Executive PSUs will fully vest on December 31, 2027, depending on the degree to which the pre-determined goals are met during the performance period. Assuming the achievement of the highest level of the performance goals, the total stock-based compensation cost for the 2025 Executive PSUs will be $138.5 million.
In February 2025, the Compensation Committee granted 11,000 PSUs to certain non-executive employees, which represent the target number of shares that can be earned based on the degree of achievement of the Company’s 2026 revenue goals for certain regions or product line divisions, or based on the degree of achievement of the Company’s two-year (2025 and 2026) average revenue growth rate compared against the analog industry’s two-year average revenue growth rate as published by the SIA (the “2025 Non-Executive PSUs”). The maximum number of shares that an employee can earn is either 200% or 300% of the target number of the 2025 Non-Executive PSUs, depending on the job classification of the employee.50% of the 2025 Non-Executive PSUs will vest in thefirst quarter of 2027 depending on the degree to which the pre-determined goals are met during the performance period. The remaining 2025 Non-Executive PSUs will vest over the following two years on a quarterly or annual basis. Assuming the achievement of the highest level of performance goals, the total stock-based compensation cost for the 2025 Non-Executive PSUs will be $16.5 million.
The 2025 Executive PSUs and the 2025 Non-Executive PSUs contain a purchase price feature, which requires the employees to pay the Company $30 per share upon vesting of the shares. The $30 purchase price requirement is deemed satisfied and waived if the Company’s stock price on the last trading day of the applicable performance period is $30 higher than the grant date stock price of $656.29. The Company determined the grant date fair value of the 2025 Executive PSUs and the 2025 Non-Executive PSUs using a Monte Carlo simulation model with the following assumptions: stock price of $656.29, simulation term ofthree years, expected volatility of 54.42%, risk-free interest rate of 4.20%, and expected dividend yield of 0.95%. The Monte Carlo simulation model for the 2025 Executive PSUs further utilized correlation coefficients of peer companies of 0.46 to 0.76. The correlation coefficients were based on peer companies in the PHLX Index as an aggregate benchmark for determining the market-based total stockholder return component. There is no illiquidity discount because the awards do not contain any post-vesting sales restrictions.
2024 PSUs:
In February 2024, the Compensation Committee granted 50,000 PSUs to the executive officers, which represent the target number of shares that can be earned based on the degree of achievement of three sets of independent performance goals (the “2024 Executive PSUs”). For the first goal, the executive officers can earn up to 300% of the target number of the 2024 Executive PSUs based on the achievement of the Company’s average three-year (2024 through 2026) revenue growth rate in excess of the analog industry’s average three-year revenue growth rate as published by the SIA. For the second goal, the executive officers can earn 100% of the target number of the 2024 Executive PSUs if the Company achieves a reduction in 2026 of 25% global combined Scope 1 and Scope 2 greenhouse gas emissions against the 2022 baseline. For the third goal, the executive officers can earn 50% of the target number of the 2024 Executive PSUs if more than one-third of the Company’s total 2026 revenue in the automotive end market is generated from Electronic Vehicle (“EV”) automakers. In addition, for the third goal, the executive officers can earn 50% of the target number of the 2024 Executive PSUs if total 2026 revenue from products enabling EV powertrains and EV 48V systems grows to 200% of the 2023 baseline. For the first goal, a percentage of the 2024 Executive PSUs will fully vest on December 31, 2026, depending on the degree to which the pre-determined goal is met during the performance period. The 2024 Executive PSUs related to the second and the third goal will fully vest on December 31, 2026 if the pre-determined goals are met during the performance period. Assuming the achievement of the highest level of the performance goals, the total stock-based compensation cost for the 2024 Executive PSUs is $154.3 million.
In February 2024, the Compensation Committee granted 11,000 PSUs to certain non-executive employees, which represented the target number of shares that could be earned based on the degree of achievement of the Company’s 2025 revenue goals for certain regions or product line divisions, or based on the degree of achievement of the Company’s average two-year (2024 and 2025) revenue growth rate compared against the analog industry’s average two-year revenue growth rate as published by the SIA (the “2024 Non-Executive PSUs”). The maximum number of shares that an employee could earn is either 200% or 300% of the target number of the 2024 Non-Executive PSUs, depending on the job classification of the employee. Based on the actual revenue achievement at the end of the performance period, a total of 24,000 shares were awarded to the non-executive employees.50% of the 2024 Non-Executive PSUs will vest in thefirst quarter of 2026 depending on the degree to which the pre-determined goals were met during the performance period. The remaining 2024 Non-Executive PSUs will vest over the following two years on a quarterly or annual basis. Based on the actual achievement of the performance goals, the total stock-based compensation cost for the 2024 Non-Executive PSUs is $15.0 million.
The 2024 Executive PSUs and the 2024 Non-Executive PSUs contain a purchase price feature, which requires the employees to pay the Company $30 per share upon vesting of the shares. The $30 purchase price requirement is deemed satisfied and waived if the Company’s stock price on the last trading day of the associated performance period is $30 higher than the grant date stock price of $632.98. This market condition was achieved for the 2024 Non-Executive PSUs. The Company determined the grant date fair value of the 2024 Executive PSUs and the 2024 Non-Executive PSUs using a Monte Carlo simulation model with the following assumptions: stock price of $632.98, simulation term ofthree years, expected volatility of 49.4%, risk-free interest rate of 4.1%, and expected dividend yield of 0.8%. There is no illiquidity discount because the awards do not contain any post-vesting sales restrictions.
2023 PSUs:
In February 2023, the Compensation Committee granted 69,000 PSUs to the executive officers, which represented the target number of shares that could be earned based on the degree of achievement of two sets of performance goals (the “2023 Executive PSUs”). For the first goal, the executive officers could earn up to 300% of the target number of the 2023 Executive PSUs based on the achievement of the Company’s average three-year (2023 through 2025) revenue growth rate in excess of the analog industry’s average three-year revenue growth rate as published by the SIA. Based on the actual revenue achievement at the end of the performance period, a total of 208,000 shares were awarded to the executive officers, which fully vested on December 31, 2025. For the second goal, the executive officers could earn up to an additional 200% of the target number of the 2023 Executive PSUs if the Company secures additional manufacturing capacity outside China during the three-year performance period. Based on the actual manufacturing capacity outside China at the end of the performance period, a total of 139,000 shares were awarded to the executive officers, which fully vested on December 31, 2025. Based on the actual achievement of the performance goals, the total stock-based compensation cost for the 2023 Executive PSUs was $156.2 million.
In February 2023, the Compensation Committee granted 13,000 PSUs to certain non-executive employees, which represented the target number of shares that could be earned based on the degree of achievement of the Company’s 2024 revenue goals for certain regions or product line divisions, or based on the degree of achievement of the Company’s average two-year (2023 and 2024) revenue growth rate compared against the analog industry’s average two-year revenue growth rate as published by the SIA (the “2023 Non-Executive PSUs”). The maximum number of shares that an employee could earn was either 200% or 300% of the target number of the 2023 Non-Executive PSUs, depending on the job classification of the employee. Based on the actual revenue achievement at the end of the performance period, a total of 23,000 shares were awarded to the non-executive employees.50% of the 2023 Non-Executive PSUs vested in the first quarter of 2025. The remaining 2023 Non-Executive PSUs vest over the following two years on an annual or quarterly basis. Based on the actual achievement of the performance goals, the total stock-based compensation cost for the 2023 Non-Executive PSUs is $10.0 million.
The 2023 Executive PSUs and the 2023 Non-Executive PSUs contained a purchase price feature, which required the employees to pay the Company $30 per share upon vesting of the shares. The $30 purchase price requirement would be deemed satisfied and waived if the Company’s stock price on the last trading day of the performance period was $30 higher than the grant date stock price of $467.62. This market condition was achieved for the 2023 Executive PSUs and 2023 Non-Executive PSUs. The Company determined the grant date fair value of the 2023 Executive PSUs and the 2023 Non-Executive PSUs using a Monte Carlo simulation model with the following assumptions: stock price of $467.62, simulation term offour years, expected volatility of 51.0%, risk-free interest rate of 3.9%, and expected dividend yield of 0.9%. There is no illiquidity discount because the awards do not contain any post-vesting sales restrictions.
2022 PSUs:
In February 2022, the Compensation Committee granted 81,000 PSUs to the executive officers, which represented the target number of shares that could be earned subject to the achievement of two sets of performance goals (the “2022 Executive PSUs”). For the first goal, the executive officers could earn up to 300% of the target number of the 2022 Executive PSUs based on the achievement of the Company’s average two-year (2022 and 2023) revenue growth rate compared against the analog industry’s average two-year revenue growth rate as published by the SIA.50% of the 2022 Executive PSUs would vest in thefirst quarter of 2024 if the pre-determined revenue goal was met during the performance period. The remaining 2022 Executive PSUs would vest over the following two years on a quarterly basis. For thesecond goal, the executive officers could earn up to an additional 200% of the target number of the 2022 Executive PSUs if the Company secured additional wafer capacity during a three-year performance period. The 2022 Executive PSUs related to the second goal would fully vest in the first quarter of 2025 if the pre-determined goal was met during the performance period. In addition, all vested shares related to the second goal would be subject to a post-vesting sales restriction period of one year. Assuming the achievement of the highest level of the performance goals, the total stock-based compensation cost for the 2022 Executive PSUs would be $142.7 million. The 2022 Executive PSUs were subsequently cancelled by the Board of Directors in October 2022. See the “2022 MSUs” section for further details.
MSUs
2022 MSUs:
In October 2022, the Compensation Committee cancelled the 2022 Executive PSUs and granted 159,000 MSUs to the executive officers as replacement awards, which represented the target number of shares that could be earned subject to the achievement of both stock price targets and stock performance compared to the companies comprising the Philadelphia Semiconductor Sector Index (“Peer Group”) over athree-year performance period from October 25, 2022 to October 25, 2025 (the “2022 Executive MSUs”). The maximum number of shares that an executive officer could earn was 500% of the target number of the 2022 Executive MSUs if: (1) the Company achieved five stock price targets ranging from $455 to $591 at any time during the performance period, and (2) the Company’s total stockholder return ranked in the 50th percentile or above relative to the Peer Group at the end of the performance period. As of December 31, 2024, all price targets had been achieved. Based on the Company’s total stockholder return relative to the Peer Group at the end of the performance period, a total of 797,000 shares were awarded to the executive officers, which fully vested on October 25, 2025. Under modification accounting, the total stock-based compensation cost was $119.2 million, which was subsequently updated to $124.3 million due to a change of application of accounting methodology. The total stock-based compensation cost of $124.3 million included the unamortized expense of $102.8 million related to the 2022 Executive PSUs on the modification date and the incremental cost of $21.5 million related to the 2022 Executive MSUs as a result of the modification.
The Company determined the grant date fair value of the 2022 Executive MSUs using a Monte Carlo simulation model with the following assumptions: stock price of $342.16, simulation term ofthree years, expected volatility of 54.0%, risk-free interest rate of 4.4%, and an expected dividend yield of 0.9%. There was no illiquidity discount because the awards did not contain any post-vesting sales restrictions.
9. STOCKHOLDERS’ EQUITY
Cash Dividend Program
The Company has a dividend program approved by its Board of Directors, pursuant to which the Company intends to pay quarterly cash dividends on its common stock. The Board of Directors declared the following cash dividends for the periods presented (in thousands, except per share amounts):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Dividend declared per share | $6.24 | $5.00 | $4.00 |
| Total amount | $300,117 | $242,459 | $190,642 |
As of December 31, 2025 and 2024, accrued dividends totaled $76.0 million and $59.8 million, respectively.
The declaration of any future cash dividends is at the discretion of the Board of Directors and will depend on, among other things, the Company’s financial condition, results of operations, capital requirements, business conditions, and other factors that the Board of Directors may deem relevant, as well as a determination that cash dividends are in the best interests of the Company’s stockholders.
The Company anticipates that cash used for future dividend payments will come from its domestic cash, cash generated from ongoing U.S. operations, and cash repatriated from certain foreign subsidiaries. The Company also anticipates that earnings from other foreign subsidiaries will continue to be indefinitely reinvested.
Cash Dividend Equivalent Rights
The Company’s RSUs contain rights to receive cash dividend equivalents, which entitle employees who hold RSUs to the same dividend value per share as holders of common stock. The dividend equivalents are accumulated and paid to the employees after the underlying RSUs vest. Dividend equivalents accumulated on the underlying RSUs are forfeited if the underlying RSUs do not vest. As of December 31, 2025 and 2024*,* accrued dividend equivalents totaled $9.4 million and $5.8 million, respectively.
Stock Repurchase Programs
In October 2023, the Board of Directors approved a stock repurchase program authorizing the Company to repurchase up to $640.0 million of its common stock, which was fully utilized as of December 31, 2024. In February 2025, the Board of Directors approved another stock repurchase program authorizing the Company to repurchase up to $500.0 million of its common stock through February 2028. Shares are retired upon repurchase. The Company repurchased approximately 8,000,1.0 million, and 7,000 shares of its common stock for an aggregate purchase price of $6.6 million, $636.2 million, and $3.7 million during the years ended December 31, 2025, 2024 and 2023, respectively.
Stock repurchased under the program may be made through open market repurchases, privately negotiated transactions or other structures in accordance with applicable state and federal securities laws, at times and in amounts as management deems appropriate. The timing and the number of any repurchased common stock will be determined by the Company’s management based on its evaluation of market conditions, legal requirements, share price, and other factors. The repurchase program does not obligate the Company to purchase any particular number of shares, and may be suspended, modified, or discontinued at any time without prior notice.
Excise taxes on the value of certain stock repurchases in excess of stock issued for employee compensation were not material for the Company’s stock repurchase programs for the years ended December 31, 2025, 2024 and 2023, respectively.
10. OTHER INCOME, NET
The components of other income, net, were as follows for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Interest income | $29,151 | $27,093 | $23,363 |
| Amortization of discount on available-for-sale securities, net | 4,103 | 20,145 | 5,277 |
| Gain on deferred compensation plan investments | 10,033 | 9,400 | 8,505 |
| Charitable commitments | (6,294) | (23,742) | (14,850) |
| Other | 587 | 658 | 1,810 |
| Total | $37,580 | $33,554 | $24,105 |
11. NET INCOME PER SHARE
The following table sets forth the computation of basic and diluted net income per share for the periods presented (in thousands, except per share amounts):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 (As Restated) | 2023 | |
| Numerator: | |||
| Net income | $621,483 | $1,592,058 | $427,374 |
| Denominator: | |||
| Weighted-average outstanding shares—basic | 48,035 | 48,599 | 47,610 |
| Effect of dilutive securities | 274 | 236 | 1,161 |
| Weighted-average outstanding shares—diluted | 48,309 | 48,835 | 48,771 |
| Net income per share: | |||
| Basic | $12.94 | $32.76 | $8.98 |
| Diluted | $12.86 | $32.60 | $8.76 |
Anti-dilutive common stock equivalents were not material for the periods presented.
12. ACQUISITION
On January 3, 2024 (the “Acquisition Date”), the Company acquired 100% of the outstanding capital stock of Axign, a Dutch company that designs and develops class-D audio ICs, targeting applications ranging from portable consumer speakers to automotive and professional-grade multi-speaker systems. Commencing on the Acquisition Date, Axign became a wholly-owned subsidiary of the Company and its results of operations have been included in the Company’s consolidated financial statements.
Purchase Consideration
The purchase consideration was $33.4 million in cash.
In connection with the acquisition, the Company incurred $0.4 million in transaction costs that were expensed as incurred and included in selling, general and administrative expenses in the Consolidated Statements of Operations.
Purchase Price Allocation
The purchase price allocation for Axign was as follows (in thousands):
| Inventory | $720 |
|---|---|
| Other tangible assets acquired, net of liabilities assumed | 1,623 |
| Intangible assets: | |
| Developed technology | 9,184 |
| IPR&D | 2,147 |
| Total identifiable net assets acquired | 13,674 |
| Goodwill | 19,724 |
| Total net assets acquired | $33,398 |
The intangible asset acquired with a finite life includes the core developed technology with an estimated remaining useful life of eight years. The acquired intangible asset with an indefinite life includes an incomplete R&D project that had not reached technological feasibility as of the Acquisition Date. The fair values of the developed technology and the IPR&D were determined using the income approach.
The goodwill arising from the acquisition was primarily attributed to the assembled workforce and synergies that are anticipated to enable the Company to develop solutions with lower power consumption in the consumer and automotive end markets using Axign’s digital feedback technology. The goodwill is not expected to be deductible for tax purposes.
13. INCOME TAXES
The components of income before income taxes were as follows for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| U.S. | $(118,484) | $(46,263) | $(15,066) |
| Foreign | 884,700 | 619,175 | 520,907 |
| Income before income taxes | $766,216 | $572,912 | $505,841 |
The components of the income tax expense (benefit), net were as follows for the periods presented (in thousands):
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 (As Restated) | 2023 | |
| Current: | |||
| Federal | $19,428 | $72,576 | $61,064 |
| State | 1,345 | 348 | 4,257 |
| Foreign | 84,284 | 11,155 | 5,702 |
| Deferred: | |||
| Federal | (314) | 2,773 | (1,705) |
| State | (212) | 160 | (744) |
| Foreign | 40,202 | (1,106,158) | 9,893 |
| Income tax expense (benefit), net | $144,733 | $(1,019,146) | $78,467 |
Beginning in 2025 annual reporting, we adopted ASU 2023-09 prospectively. Refer to Note 1, Summary of Significant Accounting Policies for additional details on the adoption of ASU 2023-09. A reconciliation of the U.S. federal statutory income tax rate to our effective tax rate pursuant to the disclosure requirements of ASU 2023-09 for the year ended December 31, 2025 is as follows (in thousands, except percentages):
| Amount | Percent | |
|---|---|---|
| U.S. federal statutory income tax rate | $160,905 | 21.0% |
| Domestic federal | ||
| Tax credits | ||
| Research credits | (19,491) | (2.5) |
| Nontaxable and nondeductible items, net | ||
| Share-based payments | 39,963 | 5.2 |
| Other | 4,064 | 0.5 |
| Cross-border tax laws | ||
| Global intangible low-taxed income | 22,514 | 2.9 |
| Subpart F income | 3,541 | 0.5 |
| Effects of changes in tax laws or rates enacted in the current period | - | - |
| Changes in valuation allowances | - | - |
| Other | 508 | 0.1 |
| Domestic state and local income taxes, net of federal effect (a) | (67) | - |
| Foreign tax effects | ||
| Switzerland | ||
| Statutory income tax rate differential | (106,770) | (13.9) |
| Cantonal taxes, net of federal effect | 59,864 | 7.8 |
| Nontaxable and nondeductible items, net | (21,381) | (2.8) |
| Other | 3,499 | 0.4 |
| Other foreign jurisdictions | (4,069) | (0.5) |
| Worldwide changes in unrecognized tax benefits | 1,653 | 0.2 |
| Effective tax rate | $144,733 | 18.9% |
| (a) | State taxes in Arizona, California and Florida make up the majority (greater than 50%) of the tax effect in this category. |
|---|
| Year Ended December 31, | ||
|---|---|---|
| 2024 (As Restated) | 2023 | |
| U.S. statutory federal tax rate | 21.0% | 21.0% |
| Foreign income tax at lower rates | (21.4) | (21.9) |
| U.S. tax impact of foreign earnings and losses | 15.1 | 14.5 |
| Changes in valuation allowance | 623.8 | 2.9 |
| Stock-based compensation | 1.9 | 2.2 |
| Return to Provision True Up Adjustment | (0.1) | (2.0) |
| Tax attributes, net of reserves | (210.4) | (1.3) |
| Effects of intercompany transactions | (608.5) | - |
| Other adjustments | 0.7 | 0.1 |
| Effective tax rate | (177.9)% | 15.5% |
The amount of cash paid for income taxes (net of refunds) is as follows (in thousands):
| Year Ended December 31, | |
|---|---|
| U.S. federal | $16,162 |
| State and local | 940 |
| Foreign | |
| Switzerland | 72,005 |
| Other foreign | 5,954 |
| Total foreign | 77,959 |
| Total income taxes paid, net | $95,061 |
The budget reconciliation bill H.R.1 (“H.R.1 Act”) signed into law on July 4, 2025, makes permanent certain expiring provisions of the 2017 Tax Cuts and Jobs Act and makes modifications to the existing tax framework. The primary impact for the current year is the immediate tax expensing of prior year unamortized and current year domestic R&D expenses and accelerated depreciation in the year ended December 31, 2025. The Company’s tax provision for the year ended December 31, 2025 includes the estimated impact of the H.R.1 Act.
In 2024, one of the Company’s foreign subsidiaries was granted a ten-year tax incentive, beginning in tax year 2025. A deferred tax benefit of $1.1 billion, net of $0.2 billion of deferred tax liability and $0.1 billion of valuation allowance, was recorded during the year ended December 31, 2024 to reflect the estimated future reductions in cash tax paid in that jurisdiction associated with the incentive. The deferred tax asset was $1.1 billion, net of $0.2 billion of deferred tax liability and $0.1 billion of valuation allowance, as of December 31, 2025.
In December 2024, the Company completed an intercompany transaction that resulted in one of its foreign subsidiaries recording a step up in the tax basis of intangible assets of $23.2 billion. This resulted in a deferred tax difference between the U.S. GAAP basis and local tax basis of the specified intangibles. The Company does not expect to realize the deferred tax asset for U.S. GAAP purposes; therefore, the Company has recorded a full valuation allowance as of December 31, 2024 and December 31, 2025.
In January 2025, the OECD released new Administrative Guidance on the application of the Global Anti-Base Erosion (“GloBE”) Model Rules. The Company will continue to evaluate the impact of this release or of other prospective guidance on its future global tax provision.
The components of net deferred tax assets consist of the following (in thousands):
| December 31, | ||
|---|---|---|
| 2025 | 2024 (As Restated) | |
| Deferred tax assets: | ||
| Tax attributes | $1,205,863 | $1,254,928 |
| Depreciation and amortization | 3,482,782 | 3,465,739 |
| Stock-based compensation | 3,977 | 3,432 |
| Deferred compensation | 10,920 | 11,202 |
| Other expenses not currently deductible | 11,357 | 9,505 |
| Deferred tax assets, gross | 4,714,899 | 4,744,806 |
| Valuation allowance | (3,617,562) | (3,608,471) |
| Deferred tax assets, net of valuation allowance | 1,097,337 | 1,136,335 |
| Deferred tax liabilities: | ||
| Undistributed foreign earnings | (781) | (953) |
| Other expenses currently deductible | (4,153) | (3,184) |
| Deferred tax liabilities | (4,934) | (4,137) |
| Net deferred tax assets | $1,092,403 | $1,132,198 |
| Reported as: | ||
| Deferred tax assets, net | $1,182,883 | $1,225,565 |
| Deferred tax liabilities | (90,480) | (93,367) |
| Net deferred tax assets | $1,092,403 | $1,132,198 |
GILTI:
The Company accounts for GILTI as a period cost.
Valuation Allowance:
The Company periodically evaluates its deferred tax assets, including a determination of whether a valuation allowance is necessary, based upon its ability to utilize the assets using a more likely than not analysis. The realizability of the Company’s most significant deferred tax asset is dependent on its ability to generate sufficient future taxable income during periods prior to the expiration of tax attributes to fully utilize these assets. As of December 31, 2025 and 2024, the Company has evaluated the realization of its deferred tax assets and recorded a valuation allowance for assets that do not meet the more-likely-than-not recognition threshold.
A reconciliation of the beginning and ending balance of valuation allowances was as follows for the periods presented (in thousands):
| Period | Balance at Beginning of Period | Additions | Reductions | Balance at End of Period |
|---|---|---|---|---|
| Year ended December 31, 2023 | $20,321 | $15,405 | $(718) | $35,008 |
| Year ended December 31, 2024 (As Restated) | $35,008 | $3,575,542 | $(2,079) | $3,608,471 |
| Year ended December 31, 2025 | $3,608,471 | $21,618 | $(12,527) | $3,617,562 |
The additions in the year ended December 31, 2024 were primarily the result of the step up in tax basis of intangible assets and a tax incentive received by one of our foreign subsidiaries. The Company has evaluated the deferred tax assets generated by each of these events and recorded a valuation allowance for any deferred tax assets that are not realizable on a more-likely-than-not basis.
Undistributed Earnings of Subsidiaries:
The Company has analyzed its global working capital and cash requirements, and has determined that it plans to repatriate cash from a foreign subsidiary on an ongoing basis to fund its future U.S.-based expenditures and dividends. For the years ended December 31, 2025 and 2024, the Company repatriated $275.0 million and $642.0 million, respectively, with immaterial tax impact, from this foreign subsidiary.
For all other foreign subsidiaries, the Company expects to indefinitely reinvest undistributed earnings to fund their operations and research and development. An actual repatriation of the undistributed earnings could be subject to additional foreign withholding taxes and U.S. state taxes. Determination of the unrecognized state and withholding deferred tax liability is not practicable at this time due to the complexities associated with the hypothetical calculation.
Other Income Tax Provision Matters
As of December 31, 2025, the state net operating loss carryforwards for income tax purposes were $4.3 million, which will expire beginning in 2031. As of December 31, 2025, the Company’s foreign net operating loss carryforwards for income tax purposes in non-U.S. jurisdictions were $19.2 million, $1.8 million of which can be carried forward indefinitely, while $17.4 million will begin to expire in 2029.
As of December 31, 2025, the Company hadno R&D tax credit carryforwards for federal income tax purposes. As of December 31, 2025, the Company had $48.2 million for state income tax purposes, which can be carried forward indefinitely.
In the event of a change in ownership, as defined under federal and state tax laws, the Company’s net operating loss and tax credit carryforwards could be subject to annual limitations. The annual limitations could result in the expiration of the net operating loss and tax credit carryforwards prior to utilization.
As of December 31, 2025, the Company had $81.1 million of unrecognized tax benefits, $66.9 million of which would affect its effective tax rate if recognized after considering the valuation allowance. As of December 31, 2024, the Company had $74.4 million of unrecognized tax benefits, $58.9 million of which would affect its effective tax rate if recognized after considering the valuation allowance.
A reconciliation of the gross unrecognized tax benefits was as follows (in thousands):
| Balance as of January 1, 2023 | $49,277 |
|---|---|
| Increase for tax position of current year | 14,108 |
| Increase for tax position of prior year | 2,209 |
| Decrease due to settlement with tax authorities | (1,926) |
| Decrease due to lapse of statute of limitation | (1,008) |
| Balance as of December 31, 2023 | 62,660 |
| Increase for tax position of current year | 18,125 |
| Increase for tax position of prior year | 2,180 |
| Decrease due to lapse of statute of limitation | (8,579) |
| Balance as of December 31, 2024 | 74,386 |
| Increase for tax position of current year | 17,411 |
| Decrease for tax position of prior year | (1,374) |
| Decrease due to lapse of statute of limitation | (9,359) |
| Balance as of December 31, 2025 | $81,064 |
The Company recognizes interest and penalties, if any, related to uncertain tax positions in its income tax provision. As of December 31, 2025 and 2024, the Company has $8.2 million and $6.3 million, respectively, of accrued interest related to uncertain tax positions, which were recorded in income tax liabilities on the Consolidated Balance Sheets.
The Company currently has reduced tax rates in its subsidiaries in Chengdu and Hangzhou, China through 2025 for performing R&D activities.
Income Tax Examination
The Company is subject to examination of its income tax returns by the U.S. IRS and other tax authorities. In general, the tax years for 2022 and forward are open for examination for U.S. federal and state income tax purposes.
14. COMMITMENTS AND CONTINGENCIES
Indemnification Provisions
The Company provides indemnification agreements to certain direct or indirect customers. The Company agrees to reimburse these parties for any damages, costs and expenses incurred by them as a result of legal actions taken against them by third parties for infringing upon third-party intellectual property rights as a result of using the Company’s products and technologies. These indemnification provisions are varied in scope and are subject to certain terms, conditions, limitations and exclusions. In addition, the Company has entered into indemnification agreements with its directors and officers.
It is not possible to predict the maximum potential amount of future payments under these agreements due to the limited history of indemnification claims and the unique facts and circumstances involved in each particular agreement. There were no indemnification liabilities incurred for the periods presented. However, there can be no assurances that the Company will not incur financial liabilities in the future as a result of these obligations, which could be material.
Purchase Commitments
The Company has outstanding purchase obligations with its suppliers and other parties that require the purchases of goods or services. The purchase obligations primarily consist of wafer and other inventory purchases, assembly and other manufacturing services, construction of manufacturing and R&D facilities, purchases of production and other equipment, and license arrangements.
Total estimated future unconditional purchase commitments to all suppliers and other parties as of December 31, 2025 were as follows (in thousands):
| 2026 | $389,767 |
| 2027 | 51,435 |
| 2028 | 486 |
| 2029 | 486 |
| Total | $442,174 |
Litigation
The Company is a party to actions and proceedings in the ordinary course of business, including challenges to the enforceability or validity of its intellectual property, claims that the Company’s products infringe on the intellectual property rights of others, and employment matters. The Company is also subject to litigation initiated by its stockholders. These proceedings often involve complex questions of fact and law and may require the expenditure of significant funds and the diversion of other resources to prosecute and defend. The Company defends itself vigorously against any such claims. Based on current information, the Company does not believe that a material loss from known matters is probable as of December 31, 2025.
15. SEGMENT AND GEOGRAPHIC INFORMATION
The Company operates inone reportable segment that includes the design, development, marketing and sale of high-performance, semiconductor-based power electronics solutions for the storage and computing, enterprise data, automotive, industrial, communications and consumer end markets. The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Specifically, the CODM uses net income that is reported on the Consolidated Statements of Operations, and cash provided by operating activities reported in the Consolidated Statements of Cash Flows, to decide whether and how much to reinvest profits into core business operations or to return to stockholders in the form of stock repurchases and dividends.
All significant segment expenses have been captured on the face of the Consolidated Statements of Operations.
The following is a summary of long-lived assets by geographic region (in thousands):
| December 31, | ||
|---|---|---|
| Country | 2025 | 2024 |
| China | $332,506 | $237,649 |
| U.S. | 165,107 | 171,514 |
| Taiwan | 65,081 | 42,388 |
| Other | 64,995 | 43,394 |
| Total | $627,689 | $494,945 |
16. SUBSEQUENT EVENTS
Cash Dividend Increase
In February 2026, the Board of Directors of the Company approved an increase in quarterly cash dividends from $1.56 per share to $2.00 per share.
17. RESTATEMENT OF PREVIOUSLY ISSUED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Restatement of Interim Financial Information (Unaudited)
In connection with the preparation of the Company's Consolidated Financial Statements as of and for the fiscal year ended December 31, 2025, the Company discovered that in the prior year it had not appropriately accounted for deferred income taxes associated with a one-time tax incentive granted by a certain foreign jurisdiction. The adjustment results in a decrease to the net income tax expense and the deferred income taxes, and the amounts were also material to the interim financial information. The Company has restated its unaudited Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, Condensed Consolidated Statement of Comprehensive Income, and Consolidated Statement of Stockholders’ Equity for the quarterly periods ended March 31, 2025, June 30, 2025, and September 30, 2025.
The impacts of the restatement are summarized below (in thousands, except per-share amounts):
RESTATED CONDENSED CONSOLIDATED BALANCE SHEET AS OF MARCH 31, 2025 (UNAUDITED)(in thousands, except par value):
| As Previously Reported · Impact of Restatement · As Restated | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | $637,354 | $ | - | $637,354 |
| Short-term investments | 389,310 | - | 389,310 | |
| Accounts receivable, net | 214,866 | - | 214,866 | |
| Inventories | 454,793 | - | 454,793 | |
| Other current assets | 92,063 | - | 92,063 | |
| Total current assets | 1,788,386 | - | 1,788,386 | |
| Property and equipment, net | 527,348 | - | 527,348 | |
| Acquisition-related intangible assets, net | 9,651 | - | 9,651 | |
| Goodwill | 25,944 | - | 25,944 | |
| Deferred tax assets, net | 1,318,457 | (100,617) | 1,217,840 | |
| Other long-term assets | 135,974 | - | 135,974 | |
| Total assets | $3,805,760 | $(100,617) | $3,705,143 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | $127,310 | $ | - | $127,310 |
| Accrued compensation and related benefits | 74,785 | - | 74,785 | |
| Other accrued liabilities | 161,306 | - | 161,306 | |
| Total current liabilities | 363,401 | - | 363,401 | |
| Income tax liabilities | 69,535 | - | 69,535 | |
| Deferred tax liabilities | - | 92,764 | 92,764 | |
| Other long-term liabilities | 105,814 | - | 105,814 | |
| Total liabilities | 538,750 | 92,764 | 631,514 | |
| Commitments and contingencies | ||||
| Stockholders’ equity: | ||||
| Common stock and additional paid-in capital: $0.001 par value; shares authorized: 150,000; shares issued and outstanding: 47,877 and 47,823, respectively | 764,959 | - | 764,959 | |
| Retained earnings | 2,545,375 | (193,381) | 2,351,994 | |
| Accumulated other comprehensive loss | (43,324) | - | (43,324) | |
| Total stockholders’ equity | 3,267,010 | (193,381) | 3,073,629 | |
| Total liabilities and stockholders’ equity | $3,805,760 | $(100,617) | $3,705,143 | |
RESTATED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THREE MONTHS ENDED MARCH 31, 2025 (UNAUDITED)(in thousands, except per-share amounts):
| As Previously Reported · Impact of Restatement · As Restated | ||||
|---|---|---|---|---|
| Revenue | $637,554 | $ | - | $637,554 |
| Cost of revenue | 284,324 | - | 284,324 | |
| Gross profit | 353,230 | - | 353,230 | |
| Operating expenses: | ||||
| Research and development | 92,227 | - | 92,227 | |
| Selling, general and administrative | 92,244 | - | 92,244 | |
| Total operating expenses | 184,471 | - | 184,471 | |
| Operating income | 168,759 | - | 168,759 | |
| Other income, net | 5,131 | - | 5,131 | |
| Income before income taxes | 173,890 | - | 173,890 | |
| Income tax expense | 40,099 | (1,261) | 38,838 | |
| Net income | $133,791 | $1,261 | $135,052 | |
| Net income per share: | ||||
| Basic | $2.80 | $0.02 | $2.82 | |
| Diluted | $2.79 | $0.02 | $2.81 | |
| Weighted-average shares outstanding: | ||||
| Basic | 47,851 | - | 47,851 | |
| Diluted | 48,006 | - | 48,006 | |
RESTATED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THREE MONTHS ENDED MARCH 31, 2025 (UNAUDITED)(in thousands):
| As Previously Reported | Impact of Restatement | As Restated | |
|---|---|---|---|
| Net income | $133,791 | $1,261 | $135,052 |
| Other comprehensive income, net of tax: | |||
| Foreign currency translation adjustments | 5,139 | - | 5,139 |
| Change in unrealized gains and losses on available-for-sale securities, net of tax of $0 and $(248), respectively | 48 | - | 48 |
| Other comprehensive income, net of tax | 5,187 | - | 5,187 |
| Comprehensive income | $138,978 | $1,261 | $140,239 |
RESTATED CONDENSED CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2025 (UNAUDITED)(in thousands, except par value):
| As Previously Reported · Impact of Restatement · As Restated | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | $787,382 | $ | - | $787,382 |
| Short-term investments | 358,695 | - | 358,695 | |
| Accounts receivable, net | 194,821 | - | 194,821 | |
| Inventories | 490,642 | - | 490,642 | |
| Other current assets | 87,217 | - | 87,217 | |
| Total current assets | 1,918,757 | - | 1,918,757 | |
| Property and equipment, net | 563,885 | - | 563,885 | |
| Acquisition-related intangible assets, net | 9,364 | - | 9,364 | |
| Goodwill | 25,944 | - | 25,944 | |
| Deferred tax assets, net | 1,309,981 | (99,948) | 1,210,033 | |
| Other long-term assets | 144,279 | - | 144,279 | |
| Total assets | $3,972,210 | $(99,948) | $3,872,262 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | $129,919 | $ | - | $129,919 |
| Accrued compensation and related benefits | 81,296 | - | 81,296 | |
| Other accrued liabilities | 172,293 | - | 172,293 | |
| Total current liabilities | 383,508 | - | 383,508 | |
| Income tax liabilities | 73,185 | - | 73,185 | |
| Deferred tax liabilities | - | 92,150 | 92,150 | |
| Other long-term liabilities | 113,449 | - | 113,449 | |
| Total liabilities | 570,142 | 92,150 | 662,292 | |
| Commitments and contingencies | ||||
| Stockholders’ equity: | ||||
| Common stock and additional paid-in capital: $0.001 par value; shares authorized: 150,000; shares issued and outstanding: 47,892 and 47,823, respectively | 822,582 | - | 822,582 | |
| Retained earnings | 2,603,177 | (192,098) | 2,411,079 | |
| Accumulated other comprehensive loss | (23,691) | - | (23,691) | |
| Total stockholders’ equity | 3,402,068 | (192,098) | 3,209,970 | |
| Total liabilities and stockholders’ equity | $3,972,210 | $(99,948) | $3,872,262 | |
RESTATED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THREE AND SIX MONTHS ENDED JUNE 30, 2025 (UNAUDITED)(in thousands, except per-share amounts):
| Three Months Ended June 30, 2025 · Six Months Ended June 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| As Previously Reported · Impact of Restatement · As Restated · As Previously Reported · Impact of Restatement · As Restated | ||||||||
| Revenue | $664,574 | $ | - | $664,574 | $1,302,128 | $ | - | $1,302,128 |
| Cost of revenue | 298,558 | - | 298,558 | 582,882 | - | 582,882 | ||
| Gross profit | 366,016 | - | 366,016 | 719,246 | - | 719,246 | ||
| Operating expenses: | ||||||||
| Research and development | 96,266 | - | 96,266 | 188,493 | - | 188,493 | ||
| Selling, general and administrative | 104,992 | - | 104,992 | 197,236 | - | 197,236 | ||
| Total operating expenses | 201,258 | - | 201,258 | 385,729 | - | 385,729 | ||
| Operating income | 164,758 | - | 164,758 | 333,517 | - | 333,517 | ||
| Other income, net | 12,220 | - | 12,220 | 17,351 | - | 17,351 | ||
| Income before income taxes | 176,978 | - | 176,978 | 350,868 | - | 350,868 | ||
| Income tax expense | 43,252 | (1,283) | 41,969 | 83,351 | (2,544) | 80,807 | ||
| Net income | $133,726 | $1,283 | $135,009 | $267,517 | $2,544 | $270,061 | ||
| Net income per share: | ||||||||
| Basic | $2.79 | $0.03 | $2.82 | $5.59 | $0.05 | $5.64 | ||
| Diluted | $2.78 | $0.03 | $2.81 | $5.57 | $0.05 | $5.62 | ||
| Weighted-average shares outstanding: | ||||||||
| Basic | 47,887 | - | 47,887 | 47,869 | - | 47,869 | ||
| Diluted | 48,019 | - | 48,019 | 48,012 | - | 48,012 | ||
RESTATED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THREE AND SIX MONTHS ENDED JUNE 30, 2025 (UNAUDITED)(in thousands):
| Three Months Ended June 30, 2025 | Six Months Ended June 30, 2025 | |||||
|---|---|---|---|---|---|---|
| As Previously Reported | Impact of Restatement | As Restated | As Previously Reported | Impact of Restatement | As Restated | |
| Net income | $133,726 | $1,283 | $135,009 | $267,517 | $2,544 | $270,061 |
| Other comprehensive income, net of tax: | ||||||
| Foreign currency translation adjustments | 19,634 | - | 19,634 | 24,773 | - | 24,773 |
| Change in unrealized gains and losses on available-for-sale securities, net of tax of $0, $50, $0 and $(198), respectively | (1) | - | (1) | 47 | - | 47 |
| Other comprehensive income, net of tax | 19,633 | - | 19,633 | 24,820 | - | 24,820 |
| Comprehensive income | $153,359 | $1,283 | $154,642 | $292,337 | $2,544 | $294,881 |
RESTATED CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2025 (UNAUDITED)(in thousands, except par value):
| As Previously Reported · Impact of Restatement · As Restated | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | $1,081,251 | $ | - | $1,081,251 |
| Short-term investments | 188,233 | - | 188,233 | |
| Accounts receivable, net | 241,560 | - | 241,560 | |
| Inventories | 505,680 | - | 505,680 | |
| Other current assets | 96,021 | - | 96,021 | |
| Total current assets | 2,112,745 | - | 2,112,745 | |
| Property and equipment, net | 597,311 | - | 597,311 | |
| Acquisition-related intangible assets, net | 9,077 | - | 9,077 | |
| Goodwill | 25,944 | - | 25,944 | |
| Deferred tax assets, net | 1,300,260 | (99,170) | 1,201,090 | |
| Other long-term assets | 161,055 | - | 161,055 | |
| Total assets | $4,206,392 | $(99,170) | $4,107,222 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | $141,689 | $ | - | $141,689 |
| Accrued compensation and related benefits | 99,602 | - | 99,602 | |
| Other accrued liabilities | 201,513 | - | 201,513 | |
| Total current liabilities | 442,804 | - | 442,804 | |
| Income tax liabilities | 78,261 | - | 78,261 | |
| Deferred tax liabilities | - | 91,436 | 91,436 | |
| Other long-term liabilities | 117,380 | - | 117,380 | |
| Total liabilities | 638,445 | 91,436 | 729,881 | |
| Commitments and contingencies | ||||
| Stockholders’ equity: | ||||
| Common stock and additional paid-in capital: $0.001 par value; shares authorized: 150,000; shares issued and outstanding: 47,905 and 47,823, respectively | 885,123 | - | 885,123 | |
| Retained earnings | 2,705,527 | (190,606) | 2,514,921 | |
| Accumulated other comprehensive loss | (22,703) | - | (22,703) | |
| Total stockholders’ equity | 3,567,947 | (190,606) | 3,377,341 | |
| Total liabilities and stockholders’ equity | $4,206,392 | $(99,170) | $4,107,222 | |
RESTATED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS FOR THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 (UNAUDITED)(in thousands, except per-share amounts):
| Three Months Ended September 30, 2025 · Nine Months Ended September 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| As Previously Reported · Impact of Restatement · As Restated · As Previously Reported · Impact of Restatement · As Restated | ||||||||
| Revenue | $737,176 | $ | - | $737,176 | $2,039,304 | $ | - | $2,039,304 |
| Cost of revenue | 330,948 | - | 330,948 | 913,830 | - | 913,830 | ||
| Gross profit | 406,228 | - | 406,228 | 1,125,474 | - | 1,125,474 | ||
| Operating expenses: | ||||||||
| Research and development | 98,173 | - | 98,173 | 286,666 | - | 286,666 | ||
| Selling, general and administrative | 112,872 | - | 112,872 | 310,108 | - | 310,108 | ||
| Total operating expenses | 211,045 | - | 211,045 | 596,774 | - | 596,774 | ||
| Operating income | 195,183 | - | 195,183 | 528,700 | - | 528,700 | ||
| Other income, net | 10,392 | - | 10,392 | 27,743 | - | 27,743 | ||
| Income before income taxes | 205,575 | - | 205,575 | 556,443 | - | 556,443 | ||
| Income tax expense | 27,301 | (1,492) | 25,809 | 110,652 | (4,036) | 106,616 | ||
| Net income | $178,274 | $1,492 | $179,766 | $445,791 | $4,036 | $449,827 | ||
| Net income per share: | ||||||||
| Basic | $3.72 | $0.03 | $3.75 | $9.31 | $0.09 | $9.40 | ||
| Diluted | $3.71 | $0.03 | $3.74 | $9.28 | $0.09 | $9.37 | ||
| Weighted-average shares outstanding: | ||||||||
| Basic | 47,898 | - | 47,898 | 47,879 | - | 47,879 | ||
| Diluted | 48,042 | - | 48,042 | 48,022 | - | 48,022 | ||
RESTATED CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 (UNAUDITED)(in thousands):
| Three Months Ended September 30, 2025 | Nine Months Ended September 30, 2025 | |||||
|---|---|---|---|---|---|---|
| As Previously Reported | Impact of Restatement | As Restated | As Previously Reported | Impact of Restatement | As Restated | |
| Net income | $178,274 | $1,492 | $179,766 | $445,791 | $4,036 | $449,827 |
| Other comprehensive income, net of tax: | ||||||
| Foreign currency translation adjustments | 919 | - | 919 | 25,692 | - | 25,692 |
| Change in unrealized gains and losses on available-for-sale securities, net of tax of $17, $37, $17 and $(161), respectively | 69 | - | 69 | 116 | - | 116 |
| Other comprehensive income, net of tax | 988 | - | 988 | 25,808 | - | 25,808 |
| Comprehensive income | $179,262 | $1,492 | $180,754 | $471,599 | $4,036 | $475,635 |
RESTATED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’** EQUITY (UNAUDITED)**(in thousands, except per-share amounts):
| Accumulated | |||||
|---|---|---|---|---|---|
| Common Stock and · Other · Total | |||||
| Additional Paid-in Capital · Retained · Comprehensive · Stockholders’ | |||||
| Shares | Amount | Earnings | Loss | Equity | |
| Balance as of January 1, 2025 (As Restated) | 47,823 | $706,817 | $2,292,819 | $(48,511) | $2,951,125 |
| Net income (As Restated) | - | - | 135,052 | - | 135,052 |
| Other comprehensive income | - | - | - | 5,187 | 5,187 |
| Dividends and dividend equivalents declared ($1.56 per share) | - | - | (75,877) | - | (75,877) |
| Common stock issued | 54 | 5,335 | - | - | 5,335 |
| Stock-based compensation expense | - | 52,807 | - | - | 52,807 |
| Balance as of March 31, 2025 (As Restated) | 47,877 | 764,959 | 2,351,994 | (43,324) | 3,073,629 |
| Net income (As Restated) | - | - | 135,009 | - | 135,009 |
| Other comprehensive income | - | - | - | 19,633 | 19,633 |
| Dividends and dividend equivalents declared ($1.56 per share) | - | - | (75,924) | - | (75,924) |
| Common stock issued | 19 | - | - | - | - |
| Repurchases of common stock | (4) | (2,484) | - | - | (2,484) |
| Stock-based compensation expense | - | 60,107 | - | - | 60,107 |
| Balance as of June 30, 2025 (As Restated) | 47,892 | 822,582 | 2,411,079 | (23,691) | 3,209,970 |
| Net income (As Restated) | - | - | 179,766 | - | 179,766 |
| Other comprehensive income | - | - | - | 988 | 988 |
| Dividends and dividend equivalents declared ($1.56 per share) | - | - | (75,924) | - | (75,924) |
| Common stock issued | 15 | 3,885 | - | - | 3,885 |
| Repurchases of common stock | (2) | (2,017) | - | - | (2,017) |
| Stock-based compensation expense | - | 60,673 | - | - | 60,673 |
| Balance as of September 30, 2025 (As Restated) | 47,905 | $885,123 | $2,514,921 | $(22,703) | $3,377,341 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.